Mar. 10 FDA Grand Rounds Live Webcast on Cutting-Edge FDA Research: Pertussis Infection and Vaccination

FDA Grand Rounds

FDA is pleased to present its March 2016 session of the FDA Grand Rounds titled The Host Response to Pertussis Infection and Vaccination. Join us for a live web cast of this session presented by Dr. Tod Merkel of FDA’s Center for Biologics and Research on:

Thursday, March 10, 2016
2:00 to 3:00 p.m. 

For more information visit our web site.  Questions about this topic can be submitted during the presentation. For those unable to view the lecture, the archived presentation will be posted after each session.

About the Presentation:

The baboon model of pertussis, developed in Dr. Merkel’s laboratory, has provided important insights into the host response to both pertussis vaccination and infection. This model continues to provide the pertussis research community with the opportunity to address important questions that shed light on the pathogenesis and vaccine-mediated protection of this important pathogen.

Dr. Merkel received his Ph.D. from the University of Virginia and postdoctoral training at the National Institutes of Health. He brings over 25 years of experience in infectious disease research and related disciplines and 15 years of vaccine regulatory experience to the study of bacterial pathogenesis and the evaluation of new vaccines. He has extensive experience developing and using animal models of bacterial infections, including murine and non-human primate models of Pertussis, murine models of Staphylococcal infection, and murine models of Anthrax.